Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label follow-up study of adjunctive levetiracetam in Japanese patients with epilepsy and generalized tonic-clonic seizures
2016-002879-96Phase 3
- Sponsor
- UCB
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in epilepsy and generalized tonic-clonic seizure (GTCS), sponsored by UCB. Primary endpoint: Incidence of treatment-emergent adverse events.
02
Drugs
levetiracetam
03
Conditions
epilepsygeneralized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on 2016-002879-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002879-96.